In-Depth Research Featuring Keryx Biopharmaceuticals and Jazz Pharmaceuticals, Inc. – A Brighter Decade Ahead for Biotech
HONG KONG, March 1 /PRNewswire/ – Today, www.WorldStreetFundamentals.com released its industry report highlighting Keryx Biopharmaceuticals
(NASDAQ: KERX) and Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ). Investors
from around the world are invited to view fundamental and technical
analysis at www.WorldStreetFundamentals.com.
Biotech is enabling creation of new drugs at a faster pace than previous
traditional pharmaceutical models. After a decade of mediocre
performance the sector appears to be approaching an inflection point.
Companies are much more conducive to focusing on productivity and
emerging markets are expected to be back to top growth by 2013.
World Street has highlighted Keryx Biopharmaceuticals due to its recent
price-movement in its historical $3.50-$4.00 value range. Several major
Wall Street firms are reiterating their “buy” ratings in anticipation
of potentially successful results in Keryx’s two Phase III trials with
the FDA, including KRX-0401 (Perifosine) and Zerenex (Ferric Citrate).
To read the report on Keryx Biopharmaceuticals (NASDAQ: KERX), visit www.WorldStreetFundamentals.com.
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) continues to perform well into
2011, breaking $20 resistance levels with strong volume. World Street
recognizes Jazz Pharmaceuticals for its recently granted patent related
to Xyrem (sodium oxybate) oral solution: “Microbiologically Sound and
Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of
Narcolepsy”. The patent, number 7,851,506, became a catalyst for recent
price movement and is already listed in the Orange Book (FDA’s Approved
Drug Products List).
To view fundamental and technical analysis on these two industry members
we encourage investors to visit: www.WorldStreetFundamentals.com.
About World Street
World Street Fundamentals is an online portal for professionals,
investors and new-comers to the markets to find in depth comprehensive
research and research tools to help guide you through the ever changing
financial markets around the world. Covering the top performers in the
hottest sectors and providing clarity to investors around the world.
FOR INFORMATIONAL PURPOSES ONLY, NO RECOMMENDATION TO BUY OR SELL
SECURITIES SHOULD BE CONSTRUED FROM THIS RELEASE. WORLD STREET HAS NO
RELATIONSHIP WITH THE ABOVE MENTIONED COMPANIES AND HAS NOT BEEN
COMPENSATED BY ANY THIRD-PARTY.
SOURCE World Street Fundamentals